The levonorgestrel-releasing intrauterine system: an updated review of the contraceptive and noncontraceptive uses

Clin Obstet Gynecol. 2007 Dec;50(4):886-97. doi: 10.1097/GRF.0b013e318159c0d9.

Abstract

The levonorgestrel containing intrauterine system is an effective and safe form of long-term yet reversible birth control. Intrauterine contraception use in the United States fell dramatically after early studies reported an association between intrauterine contraception use and later tubal infertility. Subsequent evaluation suggests that these early studies were biased. Users often experience menstrual disturbances. Informing patients of these common side effects is important to improve compliance. In addition to its contraceptive effect, the levonorgestrel intrauterine system offers potential therapeutic benefits in other clinical contexts, including menorrhagia, symptomatic fibroids, endometriosis, and endometrial suppression.

Publication types

  • Review

MeSH terms

  • Cost-Benefit Analysis
  • Endometriosis / drug therapy
  • Female
  • Female Urogenital Diseases / epidemiology
  • Female Urogenital Diseases / etiology
  • Humans
  • Infertility, Female / epidemiology
  • Infertility, Female / etiology
  • Intrauterine Devices, Medicated / adverse effects*
  • Intrauterine Devices, Medicated / standards*
  • Intrauterine Devices, Medicated / statistics & numerical data
  • Leiomyoma / drug therapy
  • Menorrhagia / drug therapy
  • Risk Assessment
  • Risk Factors